✦ LIBER ✦

PMH24 MODELING THE ECONOMIC IMPACT OF GALANTAMINE TREATMENT IN PATIENTS WITH ALZHEIMER’S DISEASE IN DIFFERENT HEALTH CARE SYSTEMS

✍ Scribed by J Caro; M Salas; A Ward; D Getsios; K Migliaccio-Walle; F Garfield

Book ID: 119592016
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 78 KB
Volume: 5
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)61089-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessing the Health and Economic Impact

Assessing the Health and Economic Impact of Galantamine Treatment in Patients with Alzheimer’s Disease in the Health Care Systems of Different Countries

✍ Dr Jaime Caro, Maribel Salas, Alexandra Ward, Denis Getsios… 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 138 KB

Assessment of health economics in Alzhei

Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK

✍ A. Ward; J. J. Caro; D. Getsios; K. Ishak; J. O'Brien; R. Bullock 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

## Abstract ## Objective To assess the long‐term health and economic impact of treating mild to moderate Alzheimer's disease (AD) with galantamine (16 mg or 24 mg per day) compared to no cholinesterase therapy in the UK. ## Methods The long‐term costs and outcomes were assessed using a model dev

PNR5: THE LONG-TERM ECONOMIC IMPACT OF T

PNR5: THE LONG-TERM ECONOMIC IMPACT OF TREATING ALZHEIMER'S PATIENTS IN SWEDEN WITH GALANTAMINE

✍ FB Garfield; D Getsios; A Mehnert; A Wallin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PND16 MODELING THE CLINICAL AND ECONOMIC

PND16 MODELING THE CLINICAL AND ECONOMIC IMPLICATIONS OF GALANTAMINE IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE IN GERMANY

✍ S Guo; L Hernández; R Wasiak; M Gaudig 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PMH17 The Economic and Social Consequenc

PMH17 The Economic and Social Consequences of Schizophrenia Treatment with Seroquel XR® (Quetiapine Prolonged Release Tablets) in Poland: Aanalysis of the Impact on the Health Care System

✍ T. Faluta; M. Rdzanek; K. Pierzgalska; B. Wróbel 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

The efficacy of galantamine in the treat

The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure

✍ J. E. Mintzer; P. Kershaw 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 2 views

## Abstract ## Background Acetylcholinesterase inhibitors (AChEIs) can provide benefits at the cognitive, behavioral, and functional levels to patients with Alzheimer's disease (AD). With more AChEIs now available, treatment considerations may include whether the patient has had prior exposure to